Results
3043
Most Popular Stocks on the market
3043 companies
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
OliX Pharmaceuticals
Market Cap: ₩1.9t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩94,000.00
7D
-6.1%
1Y
444.0%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥9.5b
Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.
300119
CN¥20.93
7D
-4.6%
1Y
55.4%
Tilray Brands
Market Cap: US$1.3b
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.
TLRY
US$1.15
7D
-5.0%
1Y
-33.9%
Chengdu Easton Biopharmaceuticals
Market Cap: CN¥9.5b
Engages in the research, development, manufacture, and commercialization of pharmaceutical products.
688513
CN¥54.85
7D
-7.3%
1Y
49.4%
CARsgen Therapeutics Holdings
Market Cap: HK$10.3b
An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.
2171
HK$18.63
7D
-11.5%
1Y
335.3%
HOB Biotech GroupLtd
Market Cap: CN¥9.4b
Operates as a in vitro diagnostic company in China and internationally.
688656
CN¥150.57
7D
-8.1%
1Y
496.3%
Ascletis Pharma
Market Cap: HK$10.3b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$10.34
7D
-3.2%
1Y
848.6%
Azenta
Market Cap: US$1.3b
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
AZTA
US$28.56
7D
-8.1%
1Y
-42.2%
Sichuan Huiyu Pharmaceutical
Market Cap: CN¥9.4b
Research and develops, produces, and sells anti-tumor and injection drugs in China and internationally.
688553
CN¥22.30
7D
-9.2%
1Y
94.1%
Arcus Biosciences
Market Cap: US$1.3b
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$12.84
7D
3.6%
1Y
-16.7%
PharmaBlock Sciences (Nanjing)
Market Cap: CN¥9.3b
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial production.
300725
CN¥40.68
7D
-2.1%
1Y
29.1%
Janux Therapeutics
Market Cap: US$1.3b
A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.
JANX
US$23.23
7D
-0.9%
1Y
-49.8%
HitGen
Market Cap: CN¥9.3b
Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.
688222
CN¥23.31
7D
-6.5%
1Y
131.9%
ST PharmLtd
Market Cap: ₩1.8t
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
A237690
₩88,900.00
7D
-5.4%
1Y
-11.2%
Alivus Life Sciences
Market Cap: ₹115.2b
Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.
ALIVUS
₹939.20
7D
-10.3%
1Y
-8.8%
GuangYuYuan Chinese Herbal Medicine
Market Cap: CN¥9.3b
GuangYuYuan Chinese Herbal Medicine Co., Ltd.
600771
CN¥18.93
7D
-2.3%
1Y
-6.7%
Syndax Pharmaceuticals
Market Cap: US$1.3b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$15.68
7D
6.1%
1Y
-17.0%
Sanofi Consumer Healthcare India
Market Cap: ₹113.8b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,940.50
7D
-4.1%
1Y
-3.2%
Nanjing Vazyme Biotech
Market Cap: CN¥9.1b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥22.88
7D
3.4%
1Y
11.6%
Shandong Xinhua Pharmaceutical
Market Cap: HK$9.9b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$7.16
7D
-3.2%
1Y
25.4%
Aurisco PharmaceuticalLtd
Market Cap: CN¥9.1b
Engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API’s), and formulations catering to the pharmaceutical market worldwide.
605116
CN¥22.33
7D
-1.5%
1Y
0.3%
Harbin Pharmaceutical Group
Market Cap: CN¥9.1b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥3.60
7D
-1.4%
1Y
5.6%
Xeris Biopharma Holdings
Market Cap: US$1.3b
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$8.18
7D
6.0%
1Y
185.0%
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
Market Cap: ₺52.7b
A pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.
GENIL
₺175.60
7D
4.2%
1Y
93.4%
Blue Jet Healthcare
Market Cap: ₹112.0b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹645.90
7D
-4.9%
1Y
25.4%
Sunflower Pharmaceutical GroupLtd
Market Cap: CN¥9.0b
Engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally.
002737
CN¥15.40
7D
-1.7%
1Y
-29.1%
Zhejiang Hisoar Pharmaceutical
Market Cap: CN¥9.0b
Engages in the manufacture of pharmaceutical products and dyes in China and internationally.
002099
CN¥5.66
7D
-10.7%
1Y
-3.1%
Cisen Pharmaceutical
Market Cap: CN¥9.0b
Research, develops, produces, and sells drug products in China and internationally.
603367
CN¥19.84
7D
-5.0%
1Y
47.9%
Stoke Therapeutics
Market Cap: US$1.3b
An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.
STOK
US$24.14
7D
5.4%
1Y
97.2%
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 62.80
7D
-6.4%
1Y
-17.5%
Acutaas Chemicals
Market Cap: ₹111.2b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹1,358.10
7D
-6.9%
1Y
58.5%
Changchun BCHT Biotechnology
Market Cap: CN¥8.9b
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.
688276
CN¥21.44
7D
-2.8%
1Y
-18.4%
Sino BiologicalInc
Market Cap: CN¥8.8b
Provides recombinant protein and antibody reagents for life science researchers worldwide.
301047
CN¥72.70
7D
-9.1%
1Y
13.6%
Zhejiang Tianyu Pharmaceutical
Market Cap: CN¥8.8b
Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.
300702
CN¥25.69
7D
-2.8%
1Y
66.4%
Shandong Lukang PharmaceuticalLtd
Market Cap: CN¥8.8b
Operates as a pharmaceutical company in China.
600789
CN¥9.82
7D
-1.0%
1Y
26.5%